HAE Haemonetics Corporation
Stable Earnings Power
B- 67.7 / 100 composite

AlphaQuality composite grade, weighted for stable earnings power businesses.

Profitability

Weight: 20%
B- 63
  • 5yr Avg ROIC 7.4%
  • Operating Margin Trend +2.29 pp/yr

Capital Efficiency

Weight: 15%
B+ 77
  • 5yr Avg ROE 13.0%
  • 5yr Share-Count CAGR -1.6%

Growth Quality

Weight: 15%
B 71
  • 5yr Revenue CAGR 8.9%
  • 5yr EPS CAGR 5.8%
  • Revenue-Growth Years (5) 4/5

Cash Generation

Weight: 15%
A- 82
  • 5yr FCF Margin 12.5%
  • 5yr FCF/NI Conversion 1.58x

Balance Sheet

Weight: 20%
C+ 61
  • Net Debt / EBITDA 3.13x
  • Interest Coverage (EBIT/Int) 5.46x
  • Altman Z-Score 2.96

Stability

Weight: 15%
C 55
  • EPS Volatility (σ/μ) 0.47
  • Negative-Revenue Years (5) 1/5
  • Piotroski F-Score 6

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Holding

4 of 5 gurus held; 2 added; 2 trimmed; 1 full exit.

Holders
4 -1
Avg Δ position
-6.0%
New buys
0
Full exits
1
As of Q2 2026